Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mederi Therapeutics
Greenwich, Connecticut, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Mederi Therapeutics commercializes minimally invasive, outpatient medical devices (Stretta, Secca) for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence. These devices use radiofrequency energy to remodel sphincter muscles, offering symptom relief and improved quality of life.
- Therapeutic areas
- Gastroenterology
- Modalities
- DeviceRadiofrequency energy device
- Industry
- Surgical Medical Devices
Beyond the preview
Go deeper on Mederi Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mederi Therapeutics.